Clinical Trials Directory

Trials / Completed

CompletedNCT02413554

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.

Rivastigmine Patch Effect on the Post-operative Delirium Limited to Femur Neck Fracture Operation in Patients at Risk of Dementia.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Delirium is a common and serious condition and is associated with adverse outcome. The elderly who have cognitive dysfunction are expected to show delirium more frequently. It is most likely that delirium represents a response to impaired cholinergic neurotransmission. Investigators aimed to establish the preventive effect of the cholinesterase inhibitor, rivastigmine patch, on the post-operative delirium limited to femur neck fracture operation in patients at risk of dementia.

Detailed description

Investigators evaluated the delirium prevention effect of rivastigmine patch in patients with femur neck fracture and cognitive impairment. Investigators measured the frequency and severity of post-operation delirium in the patch applied and non-applied subjects.

Conditions

Interventions

TypeNameDescription
DRUGRivastigmine patchacetylcholine esterase inhibitor

Timeline

Start date
2013-04-01
Primary completion
2014-03-01
Completion
2015-04-01
First posted
2015-04-10
Last updated
2015-04-10

Source: ClinicalTrials.gov record NCT02413554. Inclusion in this directory is not an endorsement.

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia. (NCT02413554) · Clinical Trials Directory